The effects of CD26/DPP IV-targeted therapy on acute allograft rejection.
Korom
S
S
Harvard Medical School, Dept of Surgery, Brigham & Women's Hospital, Boston, MA 02115, USA.
De Meester
I
I
Onodera
K
K
Stadlbauer
T H
TH
Borloo
M
M
Lambeir
A M
AM
Kupiec-Weglinski
J W
JW
D000818:Animals; D018819:Dipeptidyl Peptidase 4 / Q000096:biosynthesis* / Q000097:blood / Q000378:metabolism*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D010880:Piperidines; D011480:Protease Inhibitors; C016695:prodipin; D018819:Dipeptidyl Peptidase 4